The case of eculizumab: litigation and purchases by the Brazilian Ministry of Health

The case of eculizumab: litigation and purchases by the Brazilian Ministry of Health

ABSTRACT OBJECTIVES This study examined the purchases of eculizumab, a high-cost monoclonal antibody used in the treatment of rare diseases by Brazilian federal agencies, in terms of purchased quantities, expenditures, and prices. METHODS Eculizumab purchases made between March 2007 and December...

Full description

Bibliographic Details
Main Authors: Rosângela Caetano, Paulo Henrique Almeida Rodrigues, Marilena C Villela Corrêa, Pedro Villardi, Claudia Garcia Serpa Osorio-de-Castro
Format: Article
Language:English
Published: Universidade de São Paulo 2020-03-01
Series:Revista de Saúde Pública
Subjects:
Hemoglobinuria, Paroxysmal, drug therapy
Drug Costs
Orphan Drug Production, legislation & jurisprudence
Health’s Judicialization
Public Expenditures on Health
National Drug Policy
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89102020000100220&tlng=pt

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89102020000100220&tlng=pt

Similar Items